Shanghai Haohai Biological Technology (HKG:6826, SHA:688366) slashed the repurchase price cap under a share buyback program approved Aug. 16 to a maximum of 89.31 yuan per A share from 89.71 per A share previously, a Thursday bourse filing stated.
The move came about after the ophthalmic products manufacturer declared an interim dividend of 0.40 yuan per share for the six months ended June 30.
Shares of the company closed nearly 2% lower on Thursday.
Price (HKD): $33.05, Change: $-0.55, Percent Change: -1.64%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.